Viyash Scientific Limited, formerly known as Sequent Scientific Limited, has announced a conference call with analysts and investors to discuss its Q4FY26 financial results. The call is scheduled for Wednesday, May 20, 2026, at 4:00 PM IST. The intimation was filed with BSE Limited and the National Stock Exchange of India Limited on May 12, 2026, in compliance with Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Conference Call Details

The Q4FY26 Earnings Conference Call will bring together senior members of the company's leadership team to address analysts and investors. The following key details summarise the event:

Key Speakers

The conference call will feature participation from the following senior executives of Viyash Scientific Limited:

• Dr. Hari Babu Bodepudi – Managing Director & Group CEO
• Mr. Rajaram Narayanan – Executive Director and CEO – Animal Health
• Mr. Ramakant Singani – Chief Financial Officer

Regulatory Compliance

The intimation was submitted by Yoshita Vora, Company Secretary & Compliance Officer of Viyash Scientific Limited, to both BSE Limited and the National Stock Exchange of India Limited on May 12, 2026. The filing was made pursuant to the applicable SEBI listing regulations. Further details regarding the conference call are also available on the company's website under the Investors Section at www.viyash.com .

Viyash Scientific Limited (formerly known as Sequent Scientific Limited) has notified the stock exchanges of an upcoming Board of Directors meeting, scheduled for Tuesday, May 19, 2026. The intimation was filed pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was communicated via a letter dated May 12, 2026, signed by Company Secretary & Compliance Officer Yoshita Vora.

Board Meeting Agenda

The Board meeting has been convened to address key financial and shareholder matters for the period ended March 31, 2026. The following items are on the agenda:

Trading Window Closure

In continuation of the company's earlier intimation dated March 30, 2026, and in accordance with the Company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their Immediate Relatives, the trading window for dealing in the securities of Viyash Scientific remains closed. The closure is effective from April 01, 2026, and will continue until 48 hours after the announcement of financial results, i.e., up to May 21, 2026.

The filing was made from the company's registered office located at 3rd Floor, Srivalli's Corporate, Plot No. 290, Road No. 6, Sy. No. 33, 34P to 39, Guttala Begumpet, Jubilee Hills, Hyderabad, Shaikpet, Telangana, India - 500033.